QUALIFIES FOR COVETED “BROAD SPECTRUM” LABEL
QUEBEC CITY, Dec. 7, 2011 /CNW/ – Botaneco Corp. (“Botaneco” or the “Corporation”) (TSX-V: BOT.V – News ), announces that a few of its innate and normal Hydresia oleosome sunscreen prototypes have successfully finished the vital contrast compulsory to encounter the new U.S. Food and Drug Administration (FDA) mandate for sunscreen labeling that go in to outcome in 2012. The contrast enclosed a successful “critical wavelength” investigate that will enable sunscreen marketers utilizing Botaneco’s Hydresia oleosomes to be labeled “Broad Spectrum” indicating insurance against both ultraviolet A (UVA) and ultraviolet B (UVB) rays. Current labeling mandate on sunscreens treat roughly to one side with insurance against sunburn, that is essentially caused by UVB deviation from the sun, and do not residence UVA radiation, that contributes to skin cancer and early skin aging.
On June 14, 2011 the FDA released a matter that, is to initial time, products claiming object insurance will have to show either a product moreover protects against UVA. Sunscreens that have not successfully finished the FDA compulsory “critical wavelength” investigate indicating correct UVA insurance can not affirm the “Broad Spectrum” label. This will need marketers to place a bell tag indicating the product does not help to head off skin cancer or early skin aging.
“Marketers who instruct to have a innate sunscreen with a Broad Spectrum tag claiming to lower the chance of skin cancer and early skin aging can exercise Hydresia in to their formulations. We have been using a number of companies on Hydresia formed Broad Spectrum sunscreens and design to have the initial product launched early in 2012,” settled Dr. Jack Guth , VP Research Development at Botaneco
Dr. Guth added, “Hydresia moreover allows for reduction active part to be used in sunscreens, fixation a plan in the top difficulty of UVA insurance probable for labeling purposes. These results are an critical step in the Hydresia oleosome technology achieving worldwide acceptance in SPF sunscreen enhancement.”
About Hydresia
Hydresia is a law plant formed element proven to upgrade the performance, flexibility and/or safety of a few personal healthcare products inclusive sunscreens, moisturizers, palm sanitizers, shampoos, exfoliants and a few every day wear products. Hydresia is now used globally in over 150 marketed products and aims to reinstate containing alkali emulsifiers in the $117 billion US personal healthcare market.
About Bo taneco Corp.
Botaneco is a universal developer and marketer of innovative technologies that help manufacturers encounter the consumers flourishing urge for natural, environmentally friendly, personal healthcare products. A aggressive value to Botaneco’s law technology over normal products in the ‘green sector’ is the capability to significantly complement the opening and flexibility of these skin and hair caring products. The firm has moreover been awarded the Canadian Agri-Food Award of Excellence for its flaxseed technology marketed in the innate food industry. Botaneco binds patents for its Hydresia Oleosome, Vegetable Oil Gel, Dermylex Whey Protein and Flaxseed Dehulling technology.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that tenure is tangible in the policies of the TSX Venture Exchange) accepts shortcoming is to satisfactoriness or correctness of this release.
No comments:
Post a Comment